Brief: Nkgen Biotech's Sangwoo Park Notified Board He Will Step Down As Chairperson
March 21 (Reuters) - Nkgen Biotech Inc NKGN.O :
* NKGEN BIOTECH INC - ON MARCH 14 SANGWOO PARK NOTIFIED
BOARD OF
HIS INTENTION TO STEP DOWN AS CHAIRPERSON
* NKGEN BIOTECH INC - BOARD HAS APPOINTED PAUL Y. SONG,
COMPANY'S
CHIEF EXECUTIVE OFFICER, AS CHAIRPERSON
Source text for Eikon: ID:n0001104659-24-036676
Further company coverage: NKGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nkgen Biotech
See all newsBrief: Nkgen Biotech Expands Clinical Trial Site Network For Alzheimer’S Disease Program Across US
Brief: NKgen Biotech And Hekabio Enter Into Strategic Partnership
Brief: Nkgen Biotech Announces International And U.S. Expansion Of Phase 1/2A Troculeucel Alzheimer’S Trial
Brief: Nkgen Biotech Announces Administration Of First Dose Of Troculeucel To Stroke Patient Under FDA-Cleared Compassionate Use Program
Brief: NKGen Biotech Announces Administration Of First Dose Of Troculeucel To Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program